首页> 外文OA文献 >Dutasteride treatment over 2 years delays prostate-specific antigen progression in patients with biochemical failure after radical therapy for prostate cancer: Results from the randomised, placebo-controlled avodart after radical therapy for Prostate Cancer Study (ARTS)

【2h】

Dutasteride treatment over 2 years delays prostate-specific antigen progression in patients with biochemical failure after radical therapy for prostate cancer: Results from the randomised, placebo-controlled avodart after radical therapy for Prostate Cancer Study (ARTS)

机译：度他雄胺治疗超过2年可延缓前列腺癌根治性治疗后生化衰竭患者的前列腺特异性抗原进展：来自于前列腺癌研究（ARTS）根治性治疗后随机，安慰剂对照的avodart的结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Schröder, Fritz; Bangma, Chris; Angulo, A.F.; Alcaraz, Antonio; Colombel, Jean Frédéric; McNicholas, Tom; Tammela, Teuvo; Nandy, Indrani; Castro, Ramiro;
展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Dutasteride Treatment Over 2 Years Delays Prostate-specific Antigen Progression in Patients with Biochemical Failure After Radical Therapy for Prostate Cancer: Results from the Randomised, Placebo-controlled Avodart After Radical Therapy for Prostate Cancer Study (ARTS) [J] . Fritz Schroder, Chris Bangma, Javier C. Angulo European urology . 2013,第5期

机译：超过2年的度他雄胺治疗会延迟前列腺癌根治性治疗后生化衰竭患者的前列腺特异性抗原进展：来自前列腺癌根治性治疗后随机，安慰剂对照的Avodart的结果
2. Can dutasteride delay or prevent the progression of prostate cancer in patients with biochemical failure after radical therapy? Rationale and design of the Avodart after Radical Therapy for Prostate Cancer Study. [J] . Schroder FH, Bangma CH, Wolff JM, BJU international . 2009,第5期

机译：在进行根治性治疗后发生生化衰竭的患者中，度他雄胺能否延迟或预防前列腺癌的进展？前列腺癌根治性治疗后Avodart的原理和设计。
3. Can dutasteride delay or prevent the progression of prostate cancer in patients with biochemical failure after radical therapy? Rationale and design of the Avodart after Radical Therapy for Prostate Cancer Study. [J] . Schroder FH, Bangma CH, Wolff JM, BJU international . 2009,第5期

机译：在进行根治性治疗后发生生化衰竭的患者中，度他雄胺能否延迟或预防前列腺癌的进展？前列腺癌根治性治疗后Avodart的原理和设计。
4. HIFU Therapy for Local Recurrence of Prostate Cancer after External Beam Radiotherapy and Radical Prostatectomy - 5,5 Years Experience [C] . V.A.Solovov, M.O.Vozdvizhenskiy, Y.S.Matysh International Symposium on Therapeutic Ultrasound (2002) . 2017

机译：HIFU治疗外梁放射治疗后前列腺癌的局部复发和激进前列腺切除术 - 5.5年经验
5. Studies on human prostate-specific antigen as a tumor antigen for the immunotherapy of prostate cancer in a mouse model. [D] . Willis, Richard Allen. 2002

机译：人类前列腺特异性抗原作为一种肿瘤抗原的免疫模型在小鼠模型中的研究。
6. Survival Significance of Patients With Low Prostate-Specific Antigen and High-Grade Prostate Cancer After Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy [O] . Yadong Guo, Shiyu Mao, Aihong Zhang, 2007

机译：根治性前列腺切除术，外束放射疗法或近距离放射外束放射疗法对前列腺特异性抗原低和高级别前列腺癌患者的生存意义
7. Can dutasteride delay or prevent the progression of prostate cancer in patients with biochemical failure after radical therapy? Rationale and design of the Avodart after Radical Therapy for Prostate Cancer Study [O] . Schroeder Fritz H., Bangma Chris H., Wolff Johannes M., 2009

机译：度他雄胺可以延迟或预防根治性治疗后生化失败患者的前列腺癌进展吗？前列腺癌根治术后avodart的基本原理和设计

Dutasteride treatment over 2 years delays prostate-specific antigen progression in patients with biochemical failure after radical therapy for prostate cancer: Results from the randomised, placebo-controlled avodart after radical therapy for Prostate Cancer Study (ARTS)

著录项

引文网络

相似文献

相关主题

期刊订阅